HIGH-VOLUME · DEATH-HEAVY

buprenorphine Side Effects

buprenorphine (also sold as Subutex, Sublocade) is HIGH-VOLUME in this FAERS book #84 of 524 by FAERS report count. Signature opener: DEATH-HEAVY - 28.7% of FAERS reports list death as an outcome (25,836 of 90,121).

Data updated 2026-05-15

90,121
FAERS reports

FAERS voluntary reports, 2004 to 2025. High volume tracks exposure and reporting culture; see methodology for de-dup rules.

buprenorphine: 28.7% of FAERS reports list death as an outcome (25,836 of 90,121). Caseload stamp CASELOAD; volume band HIGH-VOLUME #84 of 524 by FAERS report count.

High-report extract for buprenorphine (Subutex): 90,121 FAERS rows (2004-2025). Top named reactions: DEATH, DRUG DEPENDENCE, OVERDOSE. Outcome stamps DEATH-HEAVY · HOSP-MID · SEX-BALANCED. FAERS is voluntary signal detection, not incidence.

Counts from the openFDA FAERS extract (2004–2025). Stamps CASELOAD · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.

DEATH leads 13,278 of 90,121 reports

DEATH
13,278
DRUG DEPENDENCE
12,452
OVERDOSE
10,911
TOXICITY TO VARIOUS AGENTS
10,722
PAIN
8,157
DRUG WITHDRAWAL SYNDROME
6,860
EMOTIONAL DISTRESS
5,436
NAUSEA
4,411
DRUG ABUSE
3,622
PRODUCT ADHESION ISSUE
3,292
APPLICATION SITE RASH
3,042
INADEQUATE ANALGESIA
3,028
DIZZINESS
2,578
RASH
2,501
APPLICATION SITE PRURITUS
2,341
VOMITING
2,308
HEADACHE
2,285
FATIGUE
1,837

Who reports · age peak 18-44 (SEX-BALANCED)

Sex coding · SEX-BALANCED

Female 35,467 (56%)
Male 27,246 (43%)
Unknown 191

Age peak 18-44 (9,031 reports)

0-17 472 (2%)
18-44 9,031 (42%)
45-64 6,943 (32%)
65-74 2,313 (11%)
75+ 2,795 (13%)

FAERS filings rising toward 2025

2004 2025

Reactions in Death Reports

Death-mentioned subset is HEAVY here (25,836 reports, 28.7%). Top co-reported reactions in that subset - voluntary, not causal.

Reaction Reports
DEATH 13,268
TOXICITY TO VARIOUS AGENTS 8,899
OVERDOSE 6,404
DRUG ABUSE 1,762
DRUG DEPENDENCE 1,610
ACCIDENTAL OVERDOSE 791
ARTHRALGIA 772
ASTHENIA 759
DIZZINESS 708
PAIN 694
ABDOMINAL PAIN UPPER 686
FATIGUE 682
CONFUSIONAL STATE 679
VOMITING 668
GENERAL PHYSICAL HEALTH DETERIORATION 660
SYSTEMIC LUPUS ERYTHEMATOSUS 640
PEMPHIGUS 635
PSORIATIC ARTHROPATHY 631
TYPE 2 DIABETES MELLITUS 628

Reactions in Hospitalization Reports

Hospitalization mid-share (10,461, 11.6%). Co-reported reactions:

Reaction Reports
TOXICITY TO VARIOUS AGENTS 1,763
DRUG ABUSE 1,069
PAIN 978
CONFUSIONAL STATE 907
OVERDOSE 861
DRUG DEPENDENCE 833
NAUSEA 825
VOMITING 824
FATIGUE 769
CONDITION AGGRAVATED 738
GENERAL PHYSICAL HEALTH DETERIORATION 721
DYSPNOEA 700
ASTHENIA 689
FALL 674
DIZZINESS 671
HEADACHE 659
ARTHRALGIA 649
MATERNAL EXPOSURE DURING PREGNANCY 640
How to read buprenorphine FAERS figures (CASELOAD · DEATH-HEAVY · HOSP-MID)

FAERS holds 90,121 voluntary reports linked to buprenorphine (Subutex, Sublocade), 2004-2025. Death is listed on 25,836 (28.7%). Hospitalization appears on 10,461 (11.6%). Top co-reported indication: Product Used For Unknown Indication.

CASELOAD books overweight common drugs and loud reporting cultures; DEATH-HEAVY is the page opener, not a per-patient risk.

Read with buprenorphine

Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-MID stamps.